Gujarat Themis Biosyn Limited has informed the Exchange about General Updates

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.2%1-day move

₹406.00

prior close

₹404.30

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.7-0.3+0.4-3.2-0.7+1.7+1.7-0.3-6.1-1.2-2.2——

Up moveDown movePending

AI summary

Gujarat Themis Biosyn Limited has announced the incorporation of a new wholly owned subsidiary named Themis Biosyn Ireland Private Limited in Ireland. The new company was incorporated on 29th May, 2026 with a share capital of 1,00,000 Euro. This is a strategic expansion move as the subsidiary will operate in the pharmaceutical industry. The parent company holds 100% of the shareholding in the new entity. This disclosure is made under Regulation 30 of SEBI Listing Regulations for material events.

Likely market impact

This represents the company's first international step, potentially opening new markets or tax-efficient structures. For shareholders, this signals geographical expansion plans but carries no immediate financial impact since the subsidiary has no turnover yet.